logo-loader
viewTissue Regenix Group PLC

Tissue Regenix chief executive steps down as illness recurs

John Samuel will resume as executive chairman until a full-time chief executive is appointed

knee
Tissue Regenix specialises in regenerative medicine and implants

Tissue Regenix PLC’s  (LON:TRX) chief executive Steve Cauldwell is to step down permanently after a recurrence of the illness that kept him away from January to June.

John Samuel will resume as executive chairman until a full-time chief executive is appointed while current COO Gareth Jones will become interim- CEO.

Cauldwell said: “ The company is at such an exciting point of commercial and operational inflection and I remain committed to being available as an adviser and mentor wherever possible."

Quick facts: Tissue Regenix Group PLC

Price: 1.46 GBX

AIM:TRX
Market: AIM
Market Cap: £17.11 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Tissue Regenix Group PLC named herein, including the promotion by the Company of Tissue Regenix Group PLC in any Content on the Site, the...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Full interview: Tissue Regenix to boost production capacity as its sees...

Tissue Regenix Group PLC's (LON:TRX) Gareth Jones tells Proactive London's Andrew Scott they're focused on initiatives to increase capacity and alleviate supply constraints as they continue to see strong demand for its products. Sales rose £500,000 to £6.1mln during the six months ended...

on 11/9/19

RNS

Price Monitoring Extension

1 day, 8 hours ago

Directorate Change

4 days, 9 hours ago

Holding(s) in Company

1 week, 2 days ago

Holding(s) in Company

1 week, 3 days ago

Holding(s) in Company

1 week, 3 days ago

Second Price Monitoring Extn

1 week, 5 days ago

Price Monitoring Extension

1 week, 5 days ago

2 min read